POSTER SESSION IV
Tuesday, March 20, 2012   —  1:00 PM - 4:30 PM
CC Exhibit Hall B3 & C


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




PANCREAS PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
282 Loss of PTEN Expression in Pancreatic Ductal Adenocarcinoma Is Associated with Poor Survival (1845)
W Foo, A Rashid, H Wang, S Hamilton, MH Katz, JE Lee, HF Gomez, JL Abbruzzese, JB Fleming, H Wang - University of Texas, M.D. Anderson Cancer Center, Houston, TX
Add
283 Ribonucleotide Reductase M2 Is Not Predictive of Adjuvant Gemcitabine Treatment Benefit in Patients with Resected Pancreatic Adenocarcinoma (1877)
H Xie, J Lin, DG Thomas, W Jiang, X Liu - Cleveland Clinic, Cleveland; Indiana University, Indianapolis; University of Michigan, Ann Arbor
Add
284 Vascular Invasion in Infiltrating Ductal Adenocarcinoma of the Pancreas Can Mimic Pancreatic Intraepithelial Neoplasia: A Histopathologic Study of 209 Cases (1854)
S-M Hong, M Goggins, CL Wolfgang, RD Schulick, BH Edil, JL Cameron, A Handra-Luca, JM Herman, RH Hruban - Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Johns Hopkins Medical Institutions, Baltimore, MD
Add
285 Clinicopathologic Characteristics and Biologic Behavior of Concurrent Pancreatic Ductal Adenocarcinoma (PDAC) (1861)
M Lew, V Morales-Oyarvide, X Liao, S Ogino, J-H Chen, MB Pitman, M Mino-Kenudson - Massachusetts General Hospital, Boston, MA; Dana-Farber Cancer Institute, Boston, MA; Brigham and Women´s Hospital, Boston, MA; Indiana University, Indianapolis, IN
Add
286 Diagnostic Accuracy of Endoscopic Ultrasound-Guided Fine- Needle Aspiration in Patients with Pancreatic Adenocarcinoma Using Histology as the Gold Standard (1852)
S Hebert-Magee, A Treece, F Mukhtar, I Eltoum - University of Alabama at Birmingham, Birmingham, AL
Add
287 Error Assessment of Cytopathologic Diagnosis of EUS-FNA of Pancreatic Ductal Carcinoma (1853)
S Hebert-Magee, A Treece, M Eloubeidi, I Eltoum - University of Alabama at Birmingham, Birmingham, AL
Add
288 Downregulation of SMAD4 Is Significantly Associated with Poor Prognosis of Pancreatic Cancer: A Clinicopathologic Study of 643 Cases in a Single Cancer Center (1846)
W Foo, M Javle, Y Li, SP Kar, V Baladandayuthapani, X Dong, D Li, D Tan - University of Texas, M.D. Anderson Cancer Center, Houston, TX
Add
289 Tumoral Epithelial and Stromal Expression of SMAD Proteins in Pancreatic Ductal Adenocarcinomas (1850)
A Handra-Luca, P Hammel, A Sauvanet, P Ruszniewski, A Couvelard - APHP Avicenne Universite Paris 13 Nord Medecine, Bobigny, France, Metropolitan; APHP Beaujon Universite Paris 7, Clichy, France, Metropolitan; APHP Bichat Claude Bernard Universite Paris 7, Paris, France, Metropolitan
Add
290 Undifferentiated Carcinomas of the Pancreas Are Characterized by KRAS Mutant Allele-Specific Imbalance (1858)
A Krasinskas, AJ Moser, S Kavala, S Chiosea - University of Pittsburgh Medical Center, Pittsburgh
Add
291 ALK Rearrangements in Pancreatic Ductal Adenocarcinoma and Neuroendocrine Tumors (1849)
RP Graham, AM Oliveira, L Zhang - Mayo Clinic, Rochester, MN
Add